AA
ZBH icon

Alta Advisers’s Zimmer Biomet ZBH Stock Holding History

Alta Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-700
Closed -$75.6K – 410
2024
Q3 		$75.6K Hold
700
– – 0.03% 357
2024
Q2 		$76K Hold
700
– – 0.04% 318
2024
Q1 		$92.4K Hold
700
– – 0.05% 294
2023
Q4 		$85.2K Hold
700
– – 0.05% 294
2023
Q3 		$78.6K Hold
700
– – 0.05% 289
2023
Q2 		$102K Hold
700
– – 0.06% 240
2023
Q1 		$90.4K Hold
700
– – 0.05% 268
2022
Q4 		$89K Hold
700
– – 0.05% 253
2022
Q3 		$73K Buy
+700
New +$76.8K 0.05% 296

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Alta Advisers's ZBH Position: Q4 2024 in Review

Alta Advisers sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 700 shares — an estimated $75.6K sold.

Alta Advisers first reported a position in ZBH in Q3 2022 and held it in 9 quarters. The position peaked at $102K in Q2 2023. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Alta Advisers reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Alta Advisers sold 700 Zimmer Biomet shares in Q4 2024, an estimated $75.6K.
  • Alta Advisers first reported a position in Zimmer Biomet in Q3 2022 and held it in 9 quarters.
  • Alta Advisers's Zimmer Biomet position peaked at $102K in Q2 2023.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Alta Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.